{"disease":{"id":"asc-h","name":"asc h"},"drugs":{"marketed":[{"drug_id":"avacopan","indication_name":"Anti-Neutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tavneos","generic_name":"AVACOPAN","company_name":"Chemocentryx","drug_phase":"marketed","molecular_target":"C5a anaphylatoxin chemotactic receptor 1","drug_class":"Complement 5a Receptor Antagonist [EPC]","quality_score":62,"revenue":"400","mechanism":"Tavneos blocks the action of a chemical called C5a, which is involved in the body's inflammatory response."},{"drug_id":"heparin","indication_name":"Maintain Patency of Indwelling Vascular Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"HEPARIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Anti-coagulant","quality_score":56,"revenue":null,"mechanism":"Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots."},{"drug_id":"caffeine","indication_name":"Vascular headache","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norgesic","generic_name":"caffeine","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Central Nervous System Stimulant [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"multihance-0-1-mmol-kg","indication_name":"MRI of the central nervous system (CNS) in adults and pediatric patients (including term neonates) to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MultiHance 0.1 mmol/kg","company_name":"Bracco Diagnostics, Inc","drug_phase":"marketed","molecular_target":"Water protons in tissue; blood-brain barrier; vascular endothelium","drug_class":"Paramagnetic contrast agent; gadolinium-based MRI contrast medium","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"oral-p2y12-receptor-blocker","indication_name":"Reduction of thrombotic cardiovascular events in patients with atherosclerotic disease, including those with a recent ischemic stroke or peripheral artery disease (PAD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Oral P2Y12 receptor blocker","company_name":"Italian Society of Invasive Cardiology","drug_phase":"marketed","molecular_target":"P2Y12 adenosine diphosphate receptor on platelet surface","drug_class":"Antiplatelet agent; P2Y12 receptor antagonist; Thienopyridine or non-thienopyridine class","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Stromal Vascular Fraction for the Treatment of Aesthetic Facial Rejuvenation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Stromal Vascular Fraction for the Treatment of Facial Wrinkles","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Stromal Vascular Fraction for the Treatment of Photoaging","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ergot","indication_name":"Vascular headache","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ergot","company_name":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"heparin-sodium","indication_name":"Maintain Patency of Indwelling Vascular Catheter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"Heparin Sodium","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Antithrombin III, Coagulation Factors Xa and IIa","drug_class":"Anticoagulant","quality_score":63,"revenue":null,"mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa."},{"drug_id":"gadopiclenol","indication_name":"Detect and visualize lesions with abnormal vascularity with MRI","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Elucirem","generic_name":"GADOPICLENOL","company_name":"Guerbet","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":47,"revenue":null,"mechanism":"Gadopiclenol enhances MRI image brightness by altering water proton relaxation rates in a magnetic field."},{"drug_id":"phenobarbitone","indication_name":"Vascular headache","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"phenobarbitone","company_name":"Institute of Child Health","drug_phase":"phase_1","molecular_target":"Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 1 group I member 3, GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"dihydroergotamine","indication_name":"Vascular headache","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Migranal","generic_name":"DIHYDROERGOTAMINE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"Ergotamine Derivative","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ergotamine","indication_name":"Vascular headache","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Migergot","generic_name":"ERGOTAMINE","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1A","drug_class":"Central Nervous System Stimulant [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"ccx168","indication_name":"Anti-Neutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tavneos","generic_name":"CCX168","company_name":"Chemocentryx","drug_phase":"discontinued","molecular_target":"C5a anaphylatoxin chemotactic receptor 1","drug_class":"Complement 5a Receptor Antagonist","quality_score":null,"revenue":null,"mechanism":"Tavneos blocks the action of a chemical called C5a, which is involved in inflammation and damage to blood vessels."},{"drug_id":"elucirem","indication_name":"Detect and visualize lesions with abnormal vascularity with MRI","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Elucirem","company_name":"Guerbet","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":16,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06406998","title":"Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD","phase":"","overall_status":"RECRUITING","enrollment_count":5461222,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT06571747","title":"Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3668428,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT06239129","title":"The Stockholm CREAtinine Measurements Project","phase":"","overall_status":"COMPLETED","enrollment_count":3200000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05837364","title":"Predicting Risk of Atrial Fibrillation and Association With Other Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":2159663,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT05285085","title":"Real World Evidence Study of Statin Use in Brazil","phase":"","overall_status":"COMPLETED","enrollment_count":2133900,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT07205978","title":"Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT07196917","title":"Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT07465926","title":"Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3","phase":"","overall_status":"COMPLETED","enrollment_count":451036,"lead_sponsor_name":"Chung Shan Medical University","has_results":false},{"nct_id":"NCT03939624","title":"Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events","phase":"","overall_status":"COMPLETED","enrollment_count":419734,"lead_sponsor_name":"Canadian Network for Observational Drug Effect Studies, CNODES","has_results":false},{"nct_id":"NCT04775836","title":"An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":300000,"lead_sponsor_name":"Ministry of Science and Technology of the People´s Republic of China","has_results":false},{"nct_id":"NCT05248412","title":"The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":250000,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT03987633","title":"EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Future Genetics Limited","has_results":false},{"nct_id":"NCT03958760","title":"Characteristics, Treatment, and Economic Burden of Patients With CVD,CKD or at High Cardiovascular Risk","phase":"","overall_status":"COMPLETED","enrollment_count":200000,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT07130968","title":"Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200000,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT03225586","title":"Prospective Urban Rural Epidemiology Study","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT03299010","title":"10-year Risk Prediction Models of Complications and Mortality of DM in Hong Kong","phase":"","overall_status":"COMPLETED","enrollment_count":141516,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT03653156","title":"China Cognition and Aging Study","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT04302974","title":"Cohort Study on Patient Outcomes, Effectiveness and Cost-effectiveness of Intervention Programmes for DM/HT Patients","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT07209774","title":"Healthspan Connect Programme of Research","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT03453073","title":"Chocolate and CVD Risk in Postmenopausal Women","phase":"","overall_status":"COMPLETED","enrollment_count":83310,"lead_sponsor_name":"Brooklyn College of the City University of New York","has_results":false},{"nct_id":"NCT06209515","title":"Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61292,"lead_sponsor_name":"Kuopio University Hospital","has_results":false},{"nct_id":"NCT07145736","title":"Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":52000,"lead_sponsor_name":"Kirby Institute","has_results":false},{"nct_id":"NCT03723382","title":"Stroke in Egyptian Clinical REgisTry","phase":"","overall_status":"UNKNOWN","enrollment_count":50000,"lead_sponsor_name":"Society of Minimally Invasive Neurological Therapeutic Procedures","has_results":false},{"nct_id":"NCT05780099","title":"Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT02425345","title":"Women's Health Initiative Strong and Healthy Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":49331,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT04584645","title":"A Digital Flu Intervention for People With Cardiovascular Conditions","phase":"NA","overall_status":"COMPLETED","enrollment_count":49138,"lead_sponsor_name":"Evidation Health","has_results":true},{"nct_id":"NCT06856772","title":"Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":42000,"lead_sponsor_name":"Tor Biering-Sørensen","has_results":false},{"nct_id":"NCT07048717","title":"The Mauritius and Rodrigues Non-Communicable Disease (NCD) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":39082,"lead_sponsor_name":"Umeå University","has_results":false},{"nct_id":"NCT07023445","title":"Patterns of Inclisiran Use in the Real World: An Analysis of US Databases","phase":"","overall_status":"COMPLETED","enrollment_count":37688,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04353232","title":"Impact of Lifetime Exposure to Air and Noise Pollution on Cardiovascular Disease and Mortality - the AIRCARD Study.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":33723,"lead_sponsor_name":"Odense University Hospital","has_results":false},{"nct_id":"NCT01287000","title":"Gulf Long-Term Follow-Up Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32658,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT06387875","title":"Cohort in Qianwan New District, Ningbo","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT04531124","title":"Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT06459934","title":"Clinical Outcomes of Cardiovascular Disease","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Xinjiang Medical University","has_results":false},{"nct_id":"NCT00526474","title":"Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":26449,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07124949","title":"Chinese Migrant Population Health Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":26000,"lead_sponsor_name":"Jinwei Tian","has_results":false},{"nct_id":"NCT03424668","title":"The European Prospective Investigation Into Cancer in Norfolk Prospective Population Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":25639,"lead_sponsor_name":"University of Cambridge","has_results":false},{"nct_id":"NCT06001073","title":"Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT00741585","title":"Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":21983,"lead_sponsor_name":"University of Vigo","has_results":false},{"nct_id":"NCT06933745","title":"Ultrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":21029,"lead_sponsor_name":"University Hospital, Akershus","has_results":false},{"nct_id":"NCT03569735","title":"Nanshan Elderly Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05023564","title":"PUMCH Dementia Longitudinal Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06311149","title":"Multicenter Evaluation of Patients Using LATITUDE Monitoring System","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"University Hospital of Ferrara","has_results":false},{"nct_id":"NCT06122961","title":"Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)","phase":"","overall_status":"COMPLETED","enrollment_count":18198,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06670677","title":"Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Aktiia SA","has_results":false},{"nct_id":"NCT04657783","title":"French National Cohort of People With Type 1 Diabetes","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Fondation Francophone pour la Recherche sur le Diabete","has_results":false},{"nct_id":"NCT07428122","title":"My Heart Counts Cardiovascular Health Study: Next Gen","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT06763549","title":"COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15000,"lead_sponsor_name":"Peerbridge Health, Inc","has_results":false},{"nct_id":"NCT02019264","title":"A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":14673,"lead_sponsor_name":"Eisai Inc.","has_results":true},{"nct_id":"NCT05542719","title":"Mexican Registry of Dyslipidemia in Patients at High Risk and Very High Risk of Atherosclerotic Cardiovascular","phase":"","overall_status":"UNKNOWN","enrollment_count":13166,"lead_sponsor_name":"Coordinación de Investigación en Salud, Mexico","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}